Harkishan Singh

A new neuromuscular blocker, initially named as Chandonium Iodide, was designed and synthesized by the research group of Professor Harkishan Singh at the Panjab University, Chandigarh. The pharmacological testing was carried out at the University at Strathclyde. The toxicity studies at the Central Drug Research Institute, Lucknow, did not reveal any adverse effects. The clinical studies were also successfully completed through the CDRI. The proceedings of the symposium on the clinical testing on Chandonium Iodide were published in the Journal of Anesthesiology and Clinical Pharmacology, 10, 109–151 (1994). The drug was cleared by the Ministry of Health, Government of India, for manufacturing and clinical use. The World Health Organization gave to the drug the INN designation Candocuronium Iodide. The drug is a potent non-depolarizing neuromuscular blocker with short duration of action. The injections can be sterilized by autoclaving. The preparation can be stored at room temperature without any loss of activity.

Professor Singh was on many academic, scientific, professional and governmental bodies. He was a member of the Committee on Education in Medicinal Chemistry of the International Union of Pure and Applied Chemistry (IUPAC), which prepared the Report on the International Education of Medicinal Chemists (IUPAC Technical Reports Number 13; 1974).

Harkishan Singh (25 November 1928 – 20 March 2020) was Professor Emeritus at the Panjab University (Chandigarh, India). He was a well recognized pharmaceutical academic, medicinal chemistry researcher and science historian. He had more than half a century experience in his respective fields to his credit. He worked at the Banaras Hindu University, University of Saugar, and the Panjab University in India, and abroad at the University of Maryland, University of Mississippi and the University of London.